Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
If overspending hit savings, concentrate on a concrete reset plan: set a short-term goal, cut a few costs, and automate a savings transfer to recover quickly.
24,735 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Bland, a San Francisco voice AI startup, raised $50 million in a Series C led by Dell Technologies Capital, defying d...
On June 17, US spot Bitcoin ETFs flipped to net red, with total outflows of $82.2 million. The day highlighted a clea...
Taiko’s Ethereum Layer 2 network has confirmed a breach in its chain state verification, prompting an urgent call for...
Cerebras’s stock sinks below its IPO price, marking a painful turn for early investors as AI-chip demand cools and th...
A growing number of retirees are weighing a single-premium immediate annuity that pays $2,600 a month from a $400,000...
Prediction-market traders are pricing a US edge after Balogun’s clearance to play in the World Cup round-of-16. Marke...
A hedge-fund short report rattled Bloom Energy, triggering a brief stock drop before a swift rebound. Investors are w...
A New York Federal Reserve study finds engineering majors lead the early- career pay pack, with computer engineering ...
Travelers Insurance shares surged after a standout quarterly report, lifting the stock well above the market. This an...
Bitcoin climbs toward new highs as Coinbase faces regulatory headlines. This piece breaks down what it means for mass...
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...